Form 10KSB40 - Annual Report Form for Small Businesses that also have a Positive Response to Item 405:
SEC Accession No. 0001104659-02-001059
Filing Date
2002-03-28
Accepted
2002-03-28 00:00:00
Documents
10
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10KSB40 j3035_10ksb40.htm 10KSB40 1509242
3 EX-10.5 j3035_ex10d5.htm EX-10.5 41598
4 EX-10.18 j3035_ex10d18.htm EX-10.18 42029
5 EX-10.19 j3035_ex10d19.htm EX-10.19 23545
6 EX-10.20 j3035_ex10d20.htm EX-10.20 40749
7 EX-10.21 j3035_ex10d21.htm EX-10.21 21279
8 EX-10.22 j3035_ex10d22.htm EX-10.22 54313
9 EX-10.23 j3035_ex10d23.htm EX-10.23 83782
10 EX-10.24 j3035_ex10d24.htm EX-10.24 43882
11 EX-23.1 j3035_ex23d1.htm EX-23.1 2553
  Complete submission text file 0001104659-02-001059.txt   1865629
Mailing Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069
Business Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069 8477932458
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10KSB40 | Act: 34 | File No.: 000-28637 | Film No.: 02592096
SIC: 2836 Biological Products, (No Diagnostic Substances)